Form 4 Tracker
Candel Therapeutics, Inc.
CADL

24 insider filings · Latest: Jul 6, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 8, 2025Jan 8 1:27 PMSchoch Charles
Proposed Sale
9,801$8.35$81.8K

View →

Nov 29, 2024Nov 29 2:17 PMTyagarajan Seshu
Proposed Sale
18,548$4.95$91.8K

View →

Nov 29, 2024Nov 29 2:15 PMTak Paul Peter
Proposed Sale
44,433$4.95$219.9K

View →

Nov 29, 2024Nov 29 2:13 PMNichols William Garrett
Proposed Sale
12,675$4.95$62.7K

View →

Nov 29, 2024Nov 29 2:12 PMBarone Francesca
Proposed Sale
20,085$4.95$99.4K

View →

Sep 23, 2024Sep 23 9:16 PMAguilar-Cordova Estuardo
Proposed Sale
28,480$7.00$199.4K

View →

Sep 13, 2024Sep 13 9:53 PMAguilar-Cordova Estuardo
Proposed Sale
28,840$6.50$187.5K

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 26, 2026Jan 28 10:00 PMFrancesca BaroneChief Scientific Officer
Grant/Award
232,000$6.01232,000(D)

View →

← Previous

Page 2 of 2